Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-05-20 Option Award |
2022-05-24 5:15 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Arnold Susan Elizabeth SVP, Technical Operations |
10,917 | $0.6813 | 41,236 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-28 7:21 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Arnold Susan Elizabeth SVP, Technical Operations |
106,250 | $0 | 106,250 (Direct) |
View |
| 2021-11-19 Option Award |
2021-11-23 6:54 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Arnold Susan Elizabeth SVP, Technical Operations |
2,559 | $2.01 | 30,319 (Direct) |
View |
| 2021-07-12 Exercise(A) |
2021-09-03 4:43 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Arnold Susan Elizabeth VP, Preclinical and Chem |
4,519 | $1.74 | 27,760 (Direct) |
View |
| 2021-07-12 Exercise(A) |
2021-09-03 4:43 pm |
2015-07-12 2021-07-12 |
PhaseBio Pharmaceuticals Inc | PHAS | Arnold Susan Elizabeth VP, Preclinical and Chem |
4,519 | $0 | 27,760 (Direct) |
View |
| 2021-07-12 Option Award |
2021-07-14 7:06 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Arnold Susan Elizabeth VP, Preclinical and Chem |
4,519 | $1.74 | 27,760 (Direct) |
View |
| 2021-05-20 Option Award |
2021-05-24 6:09 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Arnold Susan Elizabeth VP, Preclinical and Chem |
5,257 | $2.8 | 23,241 (Direct) |
View |
| 2021-02-05 Option Award |
2021-02-09 4:50 pm |
N/A 2031-02-05 |
PhaseBio Pharmaceuticals Inc | PHAS | Arnold Susan Elizabeth VP, Preclinical and Chem |
36,000 | $0 | 36,000 (Direct) |
View |
| 2020-11-20 Option Award |
2020-11-23 6:36 pm |
N/A N/A |
PhaseBio Pharmaceuticals Inc | PHAS | Arnold Susan Elizabeth VP, Preclinical and Chem |
4,832 | $3 | 17,984 (Direct) |
View |